What does CUSIP 15678U958 represent in this 13F holders report?

CUSIP 15678U958 is the security identifier for 15678U958 - CEREVEL THERAPEUTICS HLDNG I - PUT used to aggregate holder disclosures.

How many institutions held 15678U958 - CEREVEL THERAPEUTICS HLDNG I - PUT in Q2 2024?

No institutional holders were reported for 15678U958 - CEREVEL THERAPEUTICS HLDNG I - PUT in Q2 2024; review adjacent reporting periods for trend context.

CEREVEL THERAPEUTICS HLDNG I - PUT

CUSIP: 15678U958

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / PUT
Price per share: $40.89
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 15678U958?
CUSIP 15678U958 identifies 15678U958 - CEREVEL THERAPEUTICS HLDNG I - PUT in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2024
Previous quarter: Q1 2024

Recent filing periods for CUSIP 15678U958:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

CEREVEL THERAPEUTICS HLDNG I - PUT

Q2 2024 13F Holders as of 30 Jun 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CEREVEL THERAPEUTICS HLDNG I - PUT as of Q2 2024.